Special Survey of Production of Insulin Aspart Specific Antibody

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin aspart

Study type: Observational

Funder types: Industry

Identifiers

NCT01487369

ANA-1946

Details and patient eligibility

About

This study is conducted in Japan. The aim of this study is to collect data of production of insulin aspart specific antibody under normal clinical practice conditions.

Enrollment: 204 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with diabetes requiring insulin therapy

Exclusion criteria

• Patients who had a treatment history of NovoRapid® (insulin aspart)

Trial design

204 participants in 1 patient group

Insulin Aspart

Treatment:

Drug: insulin aspart